<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1376</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>1997</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>EVALUATION OF CELLULAR IMMUNE RESPONSES TO AMASTIGOTE SOLUBLE Leishmania major ANTIGENS IN RECOV ERED CASES OF CUTANEOUS LEISHMANIASIS</title>
	<subject_fa>Immunology</subject_fa>
	<subject>Immunology</subject>
	<content_type_fa>Original Research: Basic Science in Medicine</content_type_fa>
	<content_type>Original Research: Basic Science in Medicine</content_type>
	<abstract_fa></abstract_fa>
	<abstract>This study was performed in order to define the cellular immune response of
12 recovered cutaneous leishmaniasis subjects to different soluble antigens of the
amastigote form of Leishmania major. A soluble leishmanial antigen preparation
(SLA) derived from highly-purified amastigotes from infected nude mice was
fractionated by Mono Q column using Fast Protein Liquid Chromatography
(FPLC) system. Three different fractions were obtained. The lymphoproliferative
response, interferon•gamma (IFN.'Y) and interleukin•4 (JL•4) to amastigote SLA
and its three subfractions were measured. The highest proliferative response and
specific IFN.'Y production without synthesis of fL•4, was induced by the fITst
fraction of amastigote SLA. These results showed that the individuals who had
recovered from cutaneous leishmaniasis had expanded memory T- cell clones
recognizing different antigens in the first fraction of amastigote SLA.
The main and most important point of this study was the identification of one
fraction of an amastigote antigen which preferentially reacted with cells from
recovered human cutaneous leishmaniasis cases.
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cutaneous leishmaniasis, amasligote soluble L. major antigen, lymphocyte proliferation. cytokines.</keyword>
	<start_page>33</start_page>
	<end_page>38</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-398&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>SIMA</first_name>
	<middle_name></middle_name>
	<last_name>RAFATI SEYEDI YAZDI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846005238</code>
	<orcid>20031947532846005238</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Department of Immunology, Pasteur Institute of Iran, Tehran,</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>STEPHANE</first_name>
	<middle_name></middle_name>
	<last_name>COUTY-JOUVE</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846005239</code>
	<orcid>20031947532846005239</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Biochemistry, University of Lavsanne, CII-I066 Epalinges, Switzerland</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>MOHAMMAD H</first_name>
	<middle_name></middle_name>
	<last_name>ALIMOHAMADIAN</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846005240</code>
	<orcid>20031947532846005240</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>From the Department of Immunology, Pasteur Institute of Iran, Tehran,</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>YAHYA</first_name>
	<middle_name></middle_name>
	<last_name>DOWLATI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846005241</code>
	<orcid>20031947532846005241</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>the Center for Research and Training in Skin Disease and Leprosy, Tehran, Islamic Republic of Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
